Vera Therapeutics (VERA) Long-Term Investments (2021 - 2023)
Vera Therapeutics' (VERA) quarterly Long-Term Investments came in at $11000.0 in Q4 2023, down 81.03% YoY from $58000.0 in Q4 2022, and down 15.38% on a QoQ basis from $13000.0 in Q3 2023.
Vera Therapeutics (VERA) Long-Term Investments (2021 - 2023) Analysis & Trends
Vera Therapeutics (VERA) has 3 years of Long-Term Investments data on file, last reported at $11000.0 in Q4 2023.
- Quarterly Long-Term Investments fell 81.03% year-over-year to $11000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $11000.0 (down 81.03% YoY) and the FY2023 annual result came in at $11000.0, down 81.03% from the prior year.
- Long-Term Investments declined to $11000.0 in Q4 2023, from $13000.0 in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $1.5 million in Q2 2021 to a low of $11000.0 in Q4 2023.
- A 3-year average of $423000.0 and a median of $122000.0 in 2022 frame the typical range for Long-Term Investments.
- The widest YoY moves for Long-Term Investments: up 78.08% in 2022, down 93.31% in 2022.
- Tracing VERA's Long-Term Investments over 3 years: stood at $867000.0 in 2021, then slumped by 93.31% to $58000.0 in 2022, then sank by 81.03% to $11000.0 in 2023.
- The last three Long-Term Investments figures came in at $11000.0 (Q4 2023), $13000.0 (Q3 2023), and $29000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | 324,000.00 |
| Mar 31, 2022 | 580,000.00 |
| Dec 31, 2021 | 867,000.00 |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.48 Mn |